Skip to main content

Advertisement

SpringerLink
Log in

Serum α1-antitrypsin level and phenotype associated with familial moyamoya disease

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Background

Obstructive vascular lesions at the terminal portion of the internal carotid arteries are thought to be the primary and essential lesions in moyamoya disease. The etiology remains unknown. To detect possible mediators of the thickened intima of moyamoya disease, we measured serum alpha-1-antitrypsin (α1-AT) levels and characterized the phenotype of patients with familial moyamoya disease.

Patients and methods

Fifty-six individuals were examined, including 29 patients with moyamoya disease from 14 families. Serum α1-AT levels were analyzed by electroimmunoassay and genomic phenotype by isoelectric focusing.

Results

All individuals had a normal α1-AT phenotype. The average serum α1-AT level in moyamoya disease patients was significantly higher than that of normal individuals, although both were within the normal range.

Conclusions

These findings suggest that serum α1-AT level may be a marker, rather than an etiologic factor, indicating the progression of moyamoya disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aoyagi M, Fukai N, Sakamoto H, Shinkai T, Matsushima Y, Yamamoto M, Yamamoto K (1991) Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease. J Cell Physiol 147:191–198

    CAS  PubMed  Google Scholar 

  2. Aoyagi M, Ogami K, Matsushima Y, Shikata M, Yamamoto M, Yamamoto K (1995) Human leukocyte antigen in patients with moyamoya disease. Stroke 26:415–417

    CAS  PubMed  Google Scholar 

  3. Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K (1996) Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke 27:1750–1754

    CAS  PubMed  Google Scholar 

  4. Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, Boswell DR (1982) Structure and variation of human α1-antitrypsin. Nature 298:329–334

    CAS  PubMed  Google Scholar 

  5. Cox DW (1994) α1-Antitrypsin: a guardian of vascular tissue. Mayo Clin Proc 69:1123–1124

    CAS  PubMed  Google Scholar 

  6. Duranton J, Adam C, Bieth JG (1998) Kinetic mechanism of the inhibition of catepsin G by α1-antichymotrypsin and α1-proteinase inhibitor. Biochemistry 37:11239–11245

    Article  CAS  PubMed  Google Scholar 

  7. Eriksson S (1996) A 30-year perspective on α1-antitrypsin deficiency. Chest 110 [Suppl]:S237–S242

  8. Faber JP, Poller W, Weidinger S, Kirchgesser M, Schwaab R, Bidlingmaier F, Olek K (1994) Identification and DNA sequence analysis of 15 new α1-antitrypsin variants, including two PIQ0 alleles and one deficient PIM allele. Am J Hum Genet 55:1113–1121

    CAS  PubMed  Google Scholar 

  9. Fukui M (1997) Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ("moyamoya disease"). Research Committee on Spontaneous Occlusion of the Circle of Willis (moyamoya disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 [Suppl 2]:S238–S240

  10. Fukuyama Y, Osawa M, Kanai N (1992) Moyamoya disease (syndrome) and the Down syndrome. Brain Dev 14:254–256

    CAS  PubMed  Google Scholar 

  11. Ikari Y, Mulvihill E, Schwartz SM (2001) 1-Proteinase inhibitor, α1-antichymotrypsin, and, α2-macrogloblin are the antiapoptotic factors of vascular smooth muscle cells. J Biol Chem 276:11798–11830

    Article  CAS  PubMed  Google Scholar 

  12. Ikeda E (1991) Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke 22:1358–1362

    CAS  PubMed  Google Scholar 

  13. Ikeda E, Hosoda Y (1992) Spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease): with special reference to its clinicopathological identity. Brain Dev 14:251–253

    CAS  PubMed  Google Scholar 

  14. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T (1999) Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64:533–537

    Article  CAS  PubMed  Google Scholar 

  15. Ikezaki K, Han DH, Kawano T, Kinukawa N, Fukui M (1997) A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke 28:2513–2517

    CAS  PubMed  Google Scholar 

  16. Ikezaki K, Kono S, Fukui M (2001) Etiology of moyamoya disease: pathology, pathophysiology, and genetics. In: Ikezaki K (ed) Moyamoya disease. American Association of Neurological Surgeons, Rolling Meadows, pp 55–64

  17. Inoue TK, Ikezaki K, Sasazuki T, Ono T, Kamikawaji N, Matsushima T, Fukui M (1997) DNA typing of HLA in the patients with moyamoya disease. Jpn J Hum Genet 42:507–515

    CAS  PubMed  Google Scholar 

  18. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M (2000) Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15:179–182

    CAS  PubMed  Google Scholar 

  19. Kalsheker NA (1996) α1-antichymotrypsin. Int J Biochem Cell Biol 28:961–964

    Article  CAS  PubMed  Google Scholar 

  20. Kueppers F (1976) Determination of α1-antitrypsin phenotypes by isoelectric focusing in polyacrylamide gels. J Lab Clin Med 88:151–155

    CAS  PubMed  Google Scholar 

  21. Luft FC (1999) Alpha-1-antitrypsin and its relevance to human disease. J Mol Med 77:359–360

    Article  CAS  PubMed  Google Scholar 

  22. Luscher TF, Stanson AW, Houser OW, Hollier LH, Sheps SG (1986) Arterial fibromuscular dysplasia. Mayo Clin Proc 62:931–952

    Google Scholar 

  23. Masuda J, Ogata J, Yutani C (1993) Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 24:1960–1967

    CAS  PubMed  Google Scholar 

  24. Schievink WI, Prakash UBS, Piepgras DG, Mokri B (1994) α1-Antitrypsin deficiency in intracranial aneurysms and cervical artery dissection. Lancet 343:452–453

    CAS  PubMed  Google Scholar 

  25. Schievink WI, Katzmann JA, Piepgras DG, Schaid DJ (1996) Alpha-1-antitrypsin phenotypes among patients with intracranial aneurysms. J Neurosurg 84:781–784

    CAS  PubMed  Google Scholar 

  26. Schievink WI, Meyer FB, Parisi JE, Wijdicks EFM (1998) Fibromuscular dysplasia of the internal carotid artery associated with α1-antitrypsin deficiency. Neurosurgery 43:229–234

    Google Scholar 

  27. Soriano SG, Cowan DB, Proctor MR, Scott RM (2002) Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya disease. Neurosurgery 50:544–549

    PubMed  Google Scholar 

  28. St Jean P, Hart B, Webster M, Steed D, Adamson J, Powell J, Ferrell R (1996) Alpha-1-antitrypsin deficiency in aneurysmal disease. Hum Hered 46:92–97

    PubMed  Google Scholar 

  29. Yamamoto M, Aoyagi M, Tajima S, Wachi H, Fukai N, Matsushima Y, Yamamoto K (1997) Increase in elastin gene expression and protein synthesis in arterial smooth muscle cells derived from patients with moyamoya disease. Stroke 28:1733–1738

    CAS  PubMed  Google Scholar 

  30. Yamamoto M, Aoyagi M, Fukai N, Matsushima Y, Yamamoto K (1998) Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease. Stroke 29:1188–1193

    CAS  PubMed  Google Scholar 

  31. Yamamoto M, Aoyagi M, Fukai N, Matsushima Y, Yamamoto K (1999) Increase in prostaglandin E2 production by interleukin-1β in arterial smooth muscle cells derived from patients with moyamoya disease. Circ Res 85:912–918

    CAS  PubMed  Google Scholar 

  32. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue TK, Ikezaki K, Matsushima T, Fukui M (2000) Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31:930–935

    CAS  PubMed  Google Scholar 

  33. Yonekawa Y, Ogata N (1992) Spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease): with special reference to its disease entity and etiological controversy. Brain Dev 14:253–254

    CAS  PubMed  Google Scholar 

  34. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof HG (1997) Moyamoya disease in Europe: past and present status. Clin Neurol Neurosurg 99 [Suppl 2]:S58–S60

Download references

Acknowledgements

This work was supported by Grants from the Research on Cardiovascular Disease (12C-4), and the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya disease) of the Ministry of Health, Labor and Welfare of Japan.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, 3–1-1 Maidashi, 812–8582, Higashi-ku, Fukuoka, Japan

    Toshiyuki Amano, Satoshi Inoha, Chun-Ming Wu, Toshio Matsushima & Kiyonobu Ikezaki

Authors
  1. Toshiyuki Amano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satoshi Inoha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chun-Ming Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshio Matsushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kiyonobu Ikezaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toshiyuki Amano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amano, T., Inoha, S., Wu, CM. et al. Serum α1-antitrypsin level and phenotype associated with familial moyamoya disease. Childs Nerv Syst 19, 655–658 (2003). https://doi.org/10.1007/s00381-003-0799-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-003-0799-9

Keywords

Search

Navigation